Integrated pan-cancer analysis and experimental verification of the roles of tropomyosin 4 in gastric cancer.
Frontiers in immunology(2023)
摘要
TPM4 is a prospective marker for the diagnosis, treatment outcome, immunology, chemotherapy, and small molecular drugs targeted for pan-cancer treatment, including GC treatment. The lncRNA-miRNA-TPM4network regulates the mechanism underlying GC progression. TPM4 may facilitate the invasion and migration of GC cells, possibly through ECM remodeling.
更多查看译文
关键词
experiment,gastric cancer,immune infiltrating,integrative analysis,pan-cancer,tropomyosin 4
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要